Clinical Trial Update: Effects on Quality of Life Following Dysport Treatment in Post-stroke Spasticity of the Arm [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update assessing quality of life after Dysport treatment for post-stroke spasticity of the arm.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Muscle Spasticity
• Stroke

Drugs mentioned

• Dysport (abobotulinumtoxinA)

Snippet

Sponsor: Ipsen | Conditions: Cerebrovascular Accident, Muscle Spasticity | Phase 4 | Status: COMPLETED